Abstract
Genetic Engineering & Biotechnology NewsVol. 35, No. 14 GEN ExclusiveThe Antibody DilemmaShortcuts Taken by Antibody Manufacturers and End-Users Have Led to a Reproducibility CrisisJonathan Birabaharan and Carl A. AscoliJonathan BirabaharanCarl A. Ascoli, Ph.D. (E-mail Address: carl.ascoli@rockland-inc.com), is the chief science officer and Jonathan Birabaharan is a research assistant at Rockland Immunochemicals. Website: www.rockland-inc.com.Search for more papers by this author and Carl A. AscoliCarl A. Ascoli, Ph.D. (E-mail Address: carl.ascoli@rockland-inc.com), is the chief science officer and Jonathan Birabaharan is a research assistant at Rockland Immunochemicals. Website: www.rockland-inc.com.Search for more papers by this authorPublished Online:27 Jul 2015https://doi.org/10.1089/gen.35.14.03AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 35Issue 14Aug 2015 Information© 2015 by GEN PublishingTo cite this article:Jonathan Birabaharan and Carl A. Ascoli.The Antibody Dilemma.Genetic Engineering & Biotechnology News.Aug 2015.8-9.http://doi.org/10.1089/gen.35.14.03Published in Volume: 35 Issue 14: July 27, 2015PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
